These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30367192)

  • 1. Comparison of ion channel inhibitor combinations for limiting secondary degeneration following partial optic nerve transection.
    Toomey LM; Bartlett CA; Majimbi M; Gopalasingam G; Rodger J; Fitzgerald M
    Exp Brain Res; 2019 Jan; 237(1):161-171. PubMed ID: 30367192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma.
    O'Hare Doig RL; Chiha W; Giacci MK; Yates NJ; Bartlett CA; Smith NM; Hodgetts SI; Harvey AR; Fitzgerald M
    BMC Neurosci; 2017 Aug; 18(1):62. PubMed ID: 28806920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three Ca2+ channel inhibitors in combination limit chronic secondary degeneration following neurotrauma.
    Savigni DL; O'Hare Doig RL; Szymanski CR; Bartlett CA; Lozić I; Smith NM; Fitzgerald M
    Neuropharmacology; 2013 Dec; 75():380-90. PubMed ID: 23958451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing modes of delivery of a combination of ion channel inhibitors for limiting secondary degeneration following partial optic nerve transection.
    Toomey LM; Bartlett CA; Gavriel N; McGonigle T; Majimbi M; Gopalasingam G; Rodger J; Fitzgerald M
    Sci Rep; 2019 Oct; 9(1):15297. PubMed ID: 31653948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine.
    Fitzgerald M; Bartlett CA; Evill L; Rodger J; Harvey AR; Dunlop SA
    Exp Neurol; 2009 Mar; 216(1):219-30. PubMed ID: 19118550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited restoration of visual function after partial optic nerve injury; a time course study using the calcium channel blocker lomerizine.
    Selt M; Bartlett CA; Harvey AR; Dunlop SA; Fitzgerald M
    Brain Res Bull; 2010 Mar; 81(4-5):467-71. PubMed ID: 19913075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and blood-brain barrier breach remote from the primary injury following neurotrauma.
    Smith NM; Giacci MK; Gough A; Bailey C; McGonigle T; Black AMB; Clarke TO; Bartlett CA; Swaminathan Iyer K; Dunlop SA; Fitzgerald M
    J Neuroinflammation; 2018 Jul; 15(1):201. PubMed ID: 29981582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limiting oxidative stress following neurotrauma with a combination of ion channel inhibitors.
    Milbourn HR; Toomey LM; Gavriel N; Gray CGG; Gough AH; Fehily B; Giacci MK; Fitzgerald M
    Discov Med; 2017 Jun; 23(129):361-369. PubMed ID: 28877447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed treatment of secondary degeneration following acute optic nerve transection using a combination of ion channel inhibitors.
    Yates NJ; Giacci MK; O'Hare Doig RL; Chiha W; Ashworth BE; Kenna J; Bartlett CA; Fitzgerald M
    Neural Regen Res; 2017 Feb; 12(2):307-316. PubMed ID: 28400815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific combinations of ion channel inhibitors reduce excessive Ca
    O'Hare Doig RL; Bartlett CA; Smith NM; Hodgetts SI; Dunlop SA; Hool L; Fitzgerald M
    Neuroscience; 2016 Dec; 339():450-462. PubMed ID: 27725216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Cellular and Functional Changes With a Combinatorial Treatment of Ion Channel Inhibitors Following Spinal Cord Injury.
    O'Hare Doig RL; Santhakumar S; Fehily B; Raja S; Solomon T; Bartlett CA; Fitzgerald M; Hodgetts SI
    Front Mol Neurosci; 2020; 13():85. PubMed ID: 32670018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a combination of ion channel inhibitors on pathology in a model of demyelinating disease.
    Gopalasingam G; Bartlett CA; McGonigle T; Majimbi M; Warnock A; Ford A; Gough A; Toomey LM; Fitzgerald M
    Mult Scler Relat Disord; 2019 Sep; 34():1-8. PubMed ID: 31202958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin sheath decompaction, axon swelling, and functional loss during chronic secondary degeneration in rat optic nerve.
    Payne SC; Bartlett CA; Harvey AR; Dunlop SA; Fitzgerald M
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6093-101. PubMed ID: 22879411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Lycium barbarum (Wolfberry) on alleviating axonal degeneration after partial optic nerve transection.
    Li HY; Ruan YW; Kau PW; Chiu K; Chang RC; Chan HH; So KF
    Cell Transplant; 2015; 24(3):403-17. PubMed ID: 25622224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near infrared light reduces oxidative stress and preserves function in CNS tissue vulnerable to secondary degeneration following partial transection of the optic nerve.
    Fitzgerald M; Bartlett CA; Payne SC; Hart NS; Rodger J; Harvey AR; Dunlop SA
    J Neurotrauma; 2010 Nov; 27(11):2107-19. PubMed ID: 20822460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early events of secondary degeneration after partial optic nerve transection: an immunohistochemical study.
    Fitzgerald M; Bartlett CA; Harvey AR; Dunlop SA
    J Neurotrauma; 2010 Feb; 27(2):439-52. PubMed ID: 19852581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new calcium channel antagonist, lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat.
    Karim Z; Sawada A; Kawakami H; Yamamoto T; Taniguchi T
    Curr Eye Res; 2006 Mar; 31(3):273-83. PubMed ID: 16531285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive species and oxidative stress in optic nerve vulnerable to secondary degeneration.
    O'Hare Doig RL; Bartlett CA; Maghzal GJ; Lam M; Archer M; Stocker R; Fitzgerald M
    Exp Neurol; 2014 Nov; 261():136-46. PubMed ID: 24931225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine.
    Fitzgerald M; Payne SC; Bartlett CA; Evill L; Harvey AR; Dunlop SA
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5456-62. PubMed ID: 19474405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice.
    Caglayan B; Caglayan AB; Beker MC; Yalcin E; Beker M; Kelestemur T; Sertel E; Ozturk G; Kilic U; Sahin F; Kilic E
    Exp Neurol; 2017 Oct; 296():23-31. PubMed ID: 28669743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.